Monograph
A10AE56 - Insulin Degludec and Liraglutide |
Propably not porphyrinogenic |
PNP |
Rationale
Combination of two substances classified as NP (insulin degludec) and PNP (liraglutide).
For more extensive monographs, please search the individual substances insulin degludec (ATC A10AE06) and liraglutide (A10BX07).
Chemical description
Liraglutide is a human glucagon-like peptide-1 analog, with a 97 per cent sequence homology to the human hormone.
Insulin degludec is an antidiabetic pancreatic hormone consisting of two polypeptide chains, A and B, connected by two diulphide bridges.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Xultophy · Xultophy 100 eenheden/ml + 3,6 mg/ml oplossing voor injectieBelgium
Xultophy · Xultophy 100 U/ml - 3.6 mg/ml sol. inj. s.c. stylo prérempliUnited Kingdom
Xultophy · Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pensDenmark
XultophyNorway
XultophyPoland
XultophyLuxembourg
XultophyIceland
XultophyFinland
XultophyLatvia
XultophySerbia
Xultophy · Xultophy®
© NAPOS 2024